🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
Because approximately half of all mild-moderately-severe asthma is persiste...
Status
Completed
Location
University of Arizona College of Medicine
Start Date
2014-07
Trial ID
NCT02066298
Treatments Being Tested
The overall purpose of the trial is to evaluate efficacy and safety of tiot...
Status
Completed
Location
205.456.01004 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01277523
Treatments Being Tested
The objective of this trial is to compare the total and regional deposition...
Status
Completed
Location
Inamed Research GmbH & Co. KG
Start Date
2006-01-17
Trial ID
NCT00267917
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Start Date
2007-05
Trial ID
NCT00467740
Treatments Being Tested
Study to compare the lung and oropharyngeal deposition of Berodual® (fenote...
Status
Terminated
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT02176200
Treatments Being Tested
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
The purpose of this study is to determine if tiotropium Respimat will resul...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05-01
Trial ID
NCT05838703
The primary objective of this study is to assess and compare the pharmacoki...
Status
Completed
Location
Teva Investigational Site 32170
Start Date
2013-01
Trial ID
NCT01785433
This is a 16 week multicentre, multinational, randomised, double-blind, dou...
Status
Completed
Location
205.342.43002 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00350207
Treatments Being Tested